ÂÜÀòÂÒÂ×

Beatrice Breckheimer is a Scientist specializing in Non-Viral Delivery within Cell Therapy Process Research & Engineering at Bristol Myers Squibb since September 2024. Previously, Beatrice served as an Associate Scientist in iPSC Research & Development at Inceptor Bio and in CAR-T Technology Development at Bristol Myers Squibb, focusing on optimizing the manufacture of CAR T cells for cancer immunotherapy. Earlier roles include Research Assistant at Veteran's Association Puget Sound Hospital, where research investigated the effects of Ghrelin on tumor-induced cachexia, and various positions contributing to cardiology and microbiology research. Beatrice holds a Master of Science in Infectious Disease from the London School of Hygiene and Tropical Medicine and dual Bachelor's degrees in Molecular, Cellular, and Developmental Biology, and International Studies: Global Health from the University of Washington.